Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01630239 · ClinicalTrials.gov registry record · Early Phase 1
MR-Guided Laser Ablation of Hepatic Tumors
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 1
- Enrollment target
NCT01630239: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT01630239 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 1 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01630239, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a pilot study to investigate the performance of MR-guided Laser Induced Thermal Therapy (LITT) in the treatment of liver tumors.
Interventions
- PROCEDURE Laser ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-03 |
| Phase | Early Phase 1 |
What the finished NCT01630239 record still lists
NCT01630239 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Laser ablation is the first listed.
NCT01630239 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01630239 about?
NCT01630239 is a clinical study titled "MR-Guided Laser Ablation of Hepatic Tumors". This is a pilot study to investigate the performance of MR-guided Laser Induced Thermal Therapy (LITT) in the treatment of liver tumors.
What is the current status of trial NCT01630239?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 1 participants. The study started on 2012-06. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01630239?
The interventions under investigation include: Laser ablation (PROCEDURE).
Who is sponsoring clinical trial NCT01630239?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01630239's enrollment target sits among peer trials
1 1986th of 2000 the lowest of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia